These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 23181943

  • 1. Ivabradine in heart failure: hope or hype?
    Deedwania PC.
    Am J Cardiovasc Drugs; 2012 Dec 01; 12(6):357-9. PubMed ID: 23181943
    [No Abstract] [Full Text] [Related]

  • 2. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.
    Perry CM.
    Am J Cardiovasc Drugs; 2012 Dec 01; 12(6):415-26. PubMed ID: 23181944
    [Abstract] [Full Text] [Related]

  • 3. Ivabradine: Current and Future Treatment of Heart Failure.
    Thorup L, Simonsen U, Grimm D, Hedegaard ER.
    Basic Clin Pharmacol Toxicol; 2017 Aug 01; 121(2):89-97. PubMed ID: 28371247
    [Abstract] [Full Text] [Related]

  • 4. Heart rate reduction in heart failure: ivabradine or beta blockers?
    Guglin M.
    Heart Fail Rev; 2013 Jul 01; 18(4):517-28. PubMed ID: 22972475
    [Abstract] [Full Text] [Related]

  • 5. Ivabradine in heart failure: what about digoxin?
    Gorman S, Boos C.
    Lancet; 2008 Dec 20; 372(9656):2113; author reply 2113-4. PubMed ID: 19101387
    [No Abstract] [Full Text] [Related]

  • 6. Cardioprotective effects of the Ιf current inhibition by ivabradine during cardiac dysfunction.
    Su JB.
    Curr Pharm Biotechnol; 2014 Dec 20; 14(14):1213-9. PubMed ID: 24831809
    [Abstract] [Full Text] [Related]

  • 7. Effects of selective I f-channel inhibition with ivabradine on hemodynamics in a patient with restrictive cardiomyopathy.
    Wenzel P, Abegunewardene N, Münzel T.
    Clin Res Cardiol; 2009 Oct 20; 98(10):681-4. PubMed ID: 19711110
    [No Abstract] [Full Text] [Related]

  • 8. Adding ivabradine to beta-blockers in chronic heart failure: Do not rest without lowering the resting heart rate sufficiently.
    Oomman A, Bansal M.
    Indian Heart J; 2018 Oct 20; 70(2):201-203. PubMed ID: 29716694
    [No Abstract] [Full Text] [Related]

  • 9. Heart failure: A SHIFT from ion channels to clinical practice.
    Terracciano CM, Yacoub MH.
    Nat Rev Cardiol; 2010 Dec 20; 7(12):669-70. PubMed ID: 21102629
    [No Abstract] [Full Text] [Related]

  • 10. Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine.
    Doesch AO, Celik S, Ehlermann P, Frankenstein L, Zehelein J, Koch A, Katus HA, Dengler TJ.
    Transplantation; 2007 Oct 27; 84(8):988-96. PubMed ID: 17989604
    [Abstract] [Full Text] [Related]

  • 11. [Heart failure. Heart rate control prevents clinical complications].
    Einecke D.
    MMW Fortschr Med; 2010 Sep 16; 152(37):12-3. PubMed ID: 21197688
    [No Abstract] [Full Text] [Related]

  • 12. [Stable angina pectoris. Effective symptom control and cardioprotection with ivabradine].
    MMW Fortschr Med; 2010 May 27; 152(21):102-3. PubMed ID: 20608138
    [No Abstract] [Full Text] [Related]

  • 13. Selective and specific I(f) inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease.
    Ferrari R, Ceconi C.
    Expert Rev Cardiovasc Ther; 2011 Aug 27; 9(8):959-73. PubMed ID: 21878041
    [Abstract] [Full Text] [Related]

  • 14. Prescribing patterns to optimize heart rate: analysis of 1,000 consecutive outpatient appointments to a single heart failure clinic over a 6-month period.
    Dierckx R, Cleland JG, Parsons S, Putzu P, Pellicori P, Dicken B, Boyalla V, Clark AL.
    JACC Heart Fail; 2015 Mar 27; 3(3):224-30. PubMed ID: 25650369
    [Abstract] [Full Text] [Related]

  • 15. Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial).
    Volterrani M, Cice G, Caminiti G, Vitale C, D'Isa S, Perrone Filardi P, Acquistapace F, Marazzi G, Fini M, Rosano GM.
    Int J Cardiol; 2011 Sep 01; 151(2):218-24. PubMed ID: 21764469
    [Abstract] [Full Text] [Related]

  • 16. Rate control with ivabradine: angina pectoris and beyond.
    Parakh N, Bhargava B.
    Am J Cardiovasc Drugs; 2011 Sep 01; 11(1):1-12. PubMed ID: 21090826
    [Abstract] [Full Text] [Related]

  • 17. Ivabradine: Cardioprotection By and Beyond Heart Rate Reduction.
    Heusch G, Kleinbongard P.
    Drugs; 2016 May 01; 76(7):733-40. PubMed ID: 27041289
    [Abstract] [Full Text] [Related]

  • 18. [From results of BEAUTIFUL trial to results of SHIFT trial: BEAUTIFUL possibility to make a SHIFT in current guidelines].
    Lopatin IuM.
    Kardiologiia; 2011 May 01; 51(5):85-90. PubMed ID: 21649600
    [Abstract] [Full Text] [Related]

  • 19. Limited role for ivabradine in the treatment of chronic heart failure.
    Cullington D, Goode KM, Cleland JG, Clark AL.
    Heart; 2011 Dec 01; 97(23):1961-6. PubMed ID: 21917660
    [Abstract] [Full Text] [Related]

  • 20. The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT.
    Voors AA, van Veldhuisen DJ, Robertson M, Ford I, Borer JS, Böhm M, Komajda M, Swedberg K, Tavazzi L, SHIFT investigators.
    Eur J Heart Fail; 2014 Apr 01; 16(4):426-34. PubMed ID: 24504937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.